• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WCCT Global successfully completes enrollment in ethnobridging study

WCCT Global successfully completes enrollment in ethnobridging study

February 11, 2013
CenterWatch Staff

WCCT Global, a global CRO supporting phase I-IV bio-pharmaceutical and device development, announced the success of their specialized recruitment methods for ethnobridging studies.

The company has over 10 years of experience in Asian bridging studies. Its geographic location in Southern California has played a major role in enabling it to recruit qualified participants for Asian Bridging Studies. Their volunteer database includes potential volunteers of Japanese, Chinese, Taiwanese, Asian Indian, Korean and Philippine decent and has grown to be quite extensive and very valuable asset.

WCCT Global was recently chosen to recruit and conduct a very difficult Japanese special population study with very stringent inclusion and exclusion criteria. By utilizing its database in combination with their proprietary, multi-media tools were able to successfully enroll and execute the study ahead of schedule for the sponsor.

WCCT Global has carried out over 60 ethnobridging clinical trials and recruited over 1,200 Asian volunteers since 1993. The recruitment methods that WCCT Global has developed have become such a robust tool for special population studies that sponsors around the world reach out to WCCT Global to help recruit and execute a diverse panel of clinical studies.

The company has released a five-part video series on "The Role of Ethnic Bridging in Enhancing Asset Value and Accelerating Global Drug Development." This video series is to inform sponsors on the importance of developing drugs for the global market.

“We wanted to share some of the knowledge we have gained in this field over the years in order to help sponsors accelerate patient access to new medical treatments, globally,” said Mel Affrime, senior vice president, R&D, WCCT Global.

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing